Clonidine is available as a prescription medication sold under several brand names. These include Catapres, Kapvay, and Duraclon [1].
How does Clonidine work for different conditions?
Clonidine's mechanism of action involves stimulating alpha-adrenergic receptors in the brainstem. This action reduces sympathetic outflow from the central nervous system, leading to decreased blood pressure and heart rate. For ADHD, it is thought to improve attention and reduce impulsivity by affecting norepinephrine pathways [2]. In its injectable form, Duraclon, it is used for intractable cancer pain [1].
What are the different dosage forms of Clonidine?
Clonidine is available in multiple dosage forms to suit different treatment needs. Oral tablets (Catapres) are commonly prescribed for hypertension [1]. Kapvay is an extended-release tablet formulation approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents [3]. Duraclon is an epidural injection used for managing severe pain in cancer patients [1].
When does Clonidine's patent protection expire?
Patent information for specific Clonidine formulations can be complex and vary by region and innovator product. Generally, original patents for innovator drugs expire after a set period, often 20 years from the filing date. However, secondary patents related to new formulations, delivery methods, or indications can extend market exclusivity. For detailed patent expiry information for specific Clonidine products, resources like DrugPatentWatch.com can provide comprehensive data [4].
Can generic versions of Clonidine be purchased?
Yes, generic versions of Clonidine are available for many of its formulations, particularly for the immediate-release tablets used to treat hypertension [1]. The availability of generics for extended-release formulations like Kapvay may depend on the expiry of specific patents covering those innovations.
What are common side effects associated with Clonidine?
Common side effects of oral Clonidine include drowsiness, dizziness, dry mouth, and constipation. Some patients may also experience low blood pressure, fatigue, and headache. Side effects for the extended-release formulation (Kapvay) are similar, with somnolence being a frequent concern. The injectable form (Duraclon) carries risks associated with epidural administration, such as hypotension and respiratory depression [2, 3].
What is the difference between Catapres and Kapvay?
Catapres is the brand name for immediate-release Clonidine tablets, primarily used for hypertension. Kapvay is a brand name for an extended-release formulation of Clonidine, specifically approved for treating ADHD in children and adolescents. The extended-release nature of Kapvay allows for less frequent dosing and may help manage symptoms more consistently throughout the day [2, 3].
Are there any risks associated with stopping Clonidine suddenly?
Abruptly discontinuing Clonidine can lead to a rebound effect, characterized by a rapid and significant increase in blood pressure, heart rate, and potential anxiety or nervousness. This can be dangerous, especially for patients being treated for hypertension. Therefore, healthcare providers typically recommend a gradual tapering of the dose when discontinuing the medication [1, 2].
---
1. DrugPatentWatch.com
2. [Information about Clonidine - source missing]
3. [Information about Kapvay - source missing]
4. [Information about patent expiry - source missing]